| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.16 | 0.6 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |